These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 11421580

  • 1. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.
    Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): is LRP central to Alzheimer's disease pathogenesis?
    Van Uden E, Carlson G, St George-Hyslop P, Westaway D, Orlando R, Mallory M, Rockenstein E, Masliah E.
    Mol Cell Neurosci; 1999 Aug; 14(2):129-40. PubMed ID: 10479411
    [Abstract] [Full Text] [Related]

  • 4. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
    Rapp A, Gmeiner B, Hüttinger M.
    Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
    [Abstract] [Full Text] [Related]

  • 5. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
    Benezra M, Vogel T, Ben-Sasson SA, Panet A, Sehayek E, Al-Haideiri M, Decklbaum RJ, Vlodavsky I.
    J Cell Biochem; 2001 May; 81(1):114-27. PubMed ID: 11180402
    [Abstract] [Full Text] [Related]

  • 6. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.
    Pocernich CB, Sultana R, Hone E, Turchan J, Martins RN, Calabrese V, Nath A, Butterfield DA.
    J Neurosci Res; 2004 Aug 15; 77(4):532-9. PubMed ID: 15264223
    [Abstract] [Full Text] [Related]

  • 7. Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain.
    Cheng X, McAsey ME, Li M, Randall S, Cady C, Nathan BP, Struble RG.
    Neurosci Lett; 2007 Apr 24; 417(1):50-4. PubMed ID: 17346883
    [Abstract] [Full Text] [Related]

  • 8. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E.
    Umans L, Overbergh L, Serneels L, Tesseur I, Van Leuven F.
    Biol Reprod; 1999 Nov 24; 61(5):1216-25. PubMed ID: 10529267
    [Abstract] [Full Text] [Related]

  • 9. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
    Versluis AJ, Rump ET, Rensen PC, van Berkel TJ, Bijsterbosch MK.
    J Pharmacol Exp Ther; 1999 Apr 24; 289(1):1-7. PubMed ID: 10086980
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
    Hara M, Iso-O N, Satoh H, Noto H, Togo M, Ishibashi S, Kimura S, Kadowaki T, Hashimoto Y, Tsukamoto K.
    Metabolism; 2006 Aug 24; 55(8):1129-34. PubMed ID: 16839851
    [Abstract] [Full Text] [Related]

  • 11. A novel efflux-recapture process underlies the mechanism of high-density lipoprotein cholesteryl ester-selective uptake mediated by the low-density lipoprotein receptor-related protein.
    Vassiliou G, McPherson R.
    Arterioscler Thromb Vasc Biol; 2004 Sep 24; 24(9):1669-75. PubMed ID: 15178567
    [Abstract] [Full Text] [Related]

  • 12. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ, Beer FD, Vark LC, Havekes LM, Hofker MH, Willems Van Dijk K.
    Biochem J; 2000 Apr 15; 347(Pt 2):357-61. PubMed ID: 10749663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 15; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 15. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.
    Grootendorst J, Bour A, Vogel E, Kelche C, Sullivan PM, Dodart JC, Bales K, Mathis C.
    Behav Brain Res; 2005 Apr 15; 159(1):1-14. PubMed ID: 15794991
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E receptors and amyloid expression are modulated in an apolipoprotein E-dependent fashion in response to hippocampal deafferentation in rodent.
    Petit-Turcotte C, Aumont N, Blain JF, Poirier J.
    Neuroscience; 2007 Nov 30; 150(1):58-63. PubMed ID: 17935896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The low-density lipoprotein receptor-related protein associates with calnexin, calreticulin, and protein disulfide isomerase in receptor-associated-protein-deficient fibroblasts.
    Orlando RA.
    Exp Cell Res; 2004 Mar 10; 294(1):244-53. PubMed ID: 14980518
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.